20 February 2014
or decades, AstraZeneca has specialized in the discovery, development, manufacturing and marketing of prescription medicines that make a meaningful difference in the lives of patients. But we know that making great medicines is not enough – we have to ensure that those who need them can get them. And that’s why we’ve been offering patient assistance programs for more than 35 years.
In 2013, these programs, which include the AZ&Me suite of prescription savings programs and the MedImmune Assistance Program, provided nearly $975 million in savings to more than 567,000 patients in the United States. Click here for a state-by-state breakdown of savings in 2013.
“Patients are top of mind for us at AstraZeneca, whether we’re making medicines to treat some of the world’s most serious diseases, educating the public on health risks or creating programs to ensure we meet evolving healthcare needs,” said Paul Hudson, President, AstraZeneca U.S. and Executive Vice President, North America. “Our patient assistance programs reflect our commitment to patients, and we continue to work hard to ensure people can access and afford the care they need.”
AstraZeneca’s AZ&Me prescription savings programs provide free medicine to qualifying people without insurance, those in Medicare Part D, those who receive their medications through participating health care facilities, and those who have recently faced a financial challenge. The MedImmune Assistance Program provides medication free of charge to qualified patients who are uninsured, or who have been rendered uninsured by their insurance company.
For more information about the AZ&Me prescription savings programs, visit www.astrazeneca-us.com or call 1-800-AZandMe (292-6363). For additional information about the MedImmune Assistance Program, visit www.myAccess360.com or call 1-877-778-9010.